Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 4,041.71 | 509.84 | 504.79 | 90.03 |
Total Revenue | 4,041.71 | 509.84 | 504.79 | 90.03 |
Costof Revenue Total | 4,001.38 | 493.86 | 498.47 | 87.74 |
Gross Profit | 40.33 | 15.98 | 6.32 | 2.29 |
Selling/ General/ Admin Expenses Total | 0.84 | 0.98 | 0.53 | 0.19 |
Depreciation/ Amortization | 0.06 | 0.15 | 0.07 | 0.06 |
Unusual Expense( Income) | 0.00 | 0.00 | - | - |
Other Operating Expenses Total | -14.90 | 7.53 | 4.08 | 1.39 |
Total Operating Expense | 3,987.38 | 502.52 | 503.16 | 89.38 |
Operating Income | 54.33 | 7.32 | 1.63 | 0.65 |
Interest Inc( Exp) Net- Non- Op Total | -38.73 | 0.76 | -1.07 | 0.00 |
Other Net | 0.00 | 0.00 | - | 0.00 |
Net Income Before Taxes | 50.45 | 7.40 | 1.53 | 0.65 |
Provisionfor Income Taxes | 17.72 | 1.97 | 0.45 | 0.17 |
Net Income After Taxes | 32.73 | 5.43 | 1.08 | 0.48 |
Net Income Before Extra Items | 32.73 | 5.43 | 1.08 | 0.48 |
Net Income | 32.73 | 5.43 | 1.08 | 0.48 |
Total Adjustmentsto Net Income | 0.00 | - | - | - |
Income Availableto Com Excl Extra Ord | 32.73 | 5.43 | 1.08 | 0.48 |
Income Availableto Com Incl Extra Ord | 32.73 | 5.43 | 1.08 | 0.48 |
Diluted Net Income | 32.73 | 5.43 | 1.08 | 0.48 |
Diluted Weighted Average Shares | 0.36 | 10.08 | 10.08 | 10.08 |
Diluted EPS Excluding Extra Ord Items | 90.92 | 0.54 | 0.11 | 0.05 |
Diluted Normalized EPS | 90.92 | 0.54 | 0.11 | 0.05 |
Remedium Lifecare Dividend Remedium Lifecare Bonus Remedium Lifecare News Remedium Lifecare AGM Remedium Lifecare Rights Remedium Lifecare Splits Remedium Lifecare Board Meetings Remedium Lifecare Key Metrics Remedium Lifecare Shareholdings Remedium Lifecare Balance Sheet Remedium Lifecare Cashflow Remedium Lifecare Q1 Results Remedium Lifecare Q2 Results Remedium Lifecare Q3 Results Remedium Lifecare Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks